116 Radio Circle, Suite 400
Valery Sagitov, president
Softberry Inc. is a developer of bioinformatics software tools for genomics research. Its primary areas of interest and expertise are in genome annotation, functional site identification in DNA and proteins, sequence database management, genome comparison, expression data analysis, protein structure prediction and protein localization prediction.
The company provides customized solutions to analyze and compare genomes, predict and annotate their genes based on sequence and structure comparison, recognize conserved regulatory elements and define cell location of predicted proteins.
Softberry develops programs in-house and distributes them under license from outside copyrightholders. Many programs are improved versions of programs developed in academia.
Licensees of Softberry products include more than 30 pharmaceutical, biotech and agricultural companies, and scientific institutions, including Amgen Inc., Biomax Informatics AG, Celera Genomics, DeCode genetics Inc., DoubleTwist Inc., Human Genome Sciences Inc., Incyte Genomics Inc., Lexicon Genetics Inc., LION Bioscience AG, Millennium Pharmaceuticals Inc., AstraZeneca plc, Bristol-Myers Squibb Co., Janssen Pharmaceutica, Merck & Co. Inc., Monsanto Corp., Novartis Agricultural Discovery, Rhone Poulenc Rorer, Roche Bioscience, Schering AG, SmithKline Beecham plc, Syngenta, Yamanouchi Pharmaceutical Co., RIKEN Genomic Sciences Center and The Institute for Genomic Research.BioWorld MedTech